Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); On Track With Narrow Network Strategy

Jefferies reiterates a 'Buy' on Express Scripts (NASDAQ: ESRX) price target of $70.00.

Analyst, Brian Tanquilut, said, "TRICARE's decision to stick with a narrow pharmacy network that excludes Walgreen's (NYSE: WAG) provides strong validation for ESRX's limited network strategy/offering. Given the direct alignment of ESRX's incentives with its clients, we view increased adoption of cost-saving narrow pharmacy networks as a positive for ESRX."

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $62.85 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies Starts LunR Royalties Corp (LUNR:CN) at Buy
• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
• RBC Capital Downgrades Downer EDI Ltd (DOW:AU) (DNERF) to Sector Perform